Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Tandem autologous-haploidentical transplantation is a feasible and effective program for... Bone Marrow Transplantation (2018) 53:366–370 https://doi.org/10.1038/s41409-017-0032-1 CORRESPONDENCE Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma 1 1 2 2 2 1 ● ● ● ● ● ● Jacopo Mariotti Stefania Bramanti Raynier Devillier Sabine Furst Jean El Cheikh Barbara Sarina 2 2 2 1 2 ● ● ● ● ● Angela Granata Catherine Faucher Samia Harbi Lucio Morabito Pierre Jean Weiller 3,4,5 6 7 1,8 1,9 ● ● ● ● ● Christian Chabannon Jamel Mokart Rossana Mineri Carmelo Carlo-Stella Armando Santoro 2,4,5 1 Didier Blaise Luca Castagna Received: 25 May 2017 / Revised: 17 September 2017 / Accepted: 18 September 2017 / Published online: 21 December 2017 © Macmillan Publishers Limited, part of Springer Nature 2018 Introduction autologous transplant for high-risk patients according to the SFGM score, showing a 5-year PFS and OS of 46 and 57%. High dose chemotherapy (HDCT) followed by autologous A sequential program was previously shown to be fea- stem cell transplantation in chemorefractory Hodgkin lym- sible and effective for resistant HL with a 2-year event free phoma (HL) patients resulted in a disappointing long-term survival (EFS) of approximately 50% [7]. We have found progression-free survival (PFS) lower than 30–40% http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bone Marrow Transplantation Springer Journals

Loading next page...
 
/lp/springer_journal/tandem-autologous-haploidentical-transplantation-is-a-feasible-and-IYtKpagJJZ
Publisher
Springer Journals
Copyright
Copyright © 2017 by The Author(s) 2017, under exclusive licence to Macmillan Publishers Limited, part of Springer Nature
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Cell Biology; Public Health; Hematology; Stem Cells
ISSN
0268-3369
eISSN
1476-5365
D.O.I.
10.1038/s41409-017-0032-1
Publisher site
See Article on Publisher Site

Abstract

Bone Marrow Transplantation (2018) 53:366–370 https://doi.org/10.1038/s41409-017-0032-1 CORRESPONDENCE Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma 1 1 2 2 2 1 ● ● ● ● ● ● Jacopo Mariotti Stefania Bramanti Raynier Devillier Sabine Furst Jean El Cheikh Barbara Sarina 2 2 2 1 2 ● ● ● ● ● Angela Granata Catherine Faucher Samia Harbi Lucio Morabito Pierre Jean Weiller 3,4,5 6 7 1,8 1,9 ● ● ● ● ● Christian Chabannon Jamel Mokart Rossana Mineri Carmelo Carlo-Stella Armando Santoro 2,4,5 1 Didier Blaise Luca Castagna Received: 25 May 2017 / Revised: 17 September 2017 / Accepted: 18 September 2017 / Published online: 21 December 2017 © Macmillan Publishers Limited, part of Springer Nature 2018 Introduction autologous transplant for high-risk patients according to the SFGM score, showing a 5-year PFS and OS of 46 and 57%. High dose chemotherapy (HDCT) followed by autologous A sequential program was previously shown to be fea- stem cell transplantation in chemorefractory Hodgkin lym- sible and effective for resistant HL with a 2-year event free phoma (HL) patients resulted in a disappointing long-term survival (EFS) of approximately 50% [7]. We have found progression-free survival (PFS) lower than 30–40%

Journal

Bone Marrow TransplantationSpringer Journals

Published: Dec 21, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off